The White House hopes to expand US modern biotech manufacturing and reduce reliance on foreign sources of bioindustrial materials.
An important component of the White House initiative to speed the development of innovative cancer therapies and other critical treatments for patients is to expand modern biotech manufacturing in the United States. The effort also aims to reduce US reliance on foreign sources of bioindustrial materials to avoid supply chain disruptions experienced during the pandemic. President Joe Biden unveiled the National Biotechnology and Biomanufacturing Initiative (NBBI) in a speech on Sept. 12, 2022 to promote his long-sought Cancer Moonshot, while also announcing a new director for the Advanced Research Projects Agency for Health (ARPA-H).
